Webcast Recording

PDF cover

ICER’s Value Framework and Patient Feedback: Q&A with Steve Pearson

ICER conducted a fireside chat moderated by Tanisha Carino, ICER Board member and Executive Director of FasterCures, with Steve Pearson, ICER’s Founder and President.  This hour-long conversation explored the mission of ICER, with an emphasis on ICER’s Value Assessment Framework revisions.  Hear about the suggestions ICER received as part of its recent public comment period, proposed changes, and how you and your organization can continue to be part of improving our process.  This webinar was intended for patient organizations and was open to the public.

Tanisha Carino, Ph.D

Tanisha Carino, Ph.D.,  is the executive director of FasterCures, a center of the Milken Institute, and an ICER board member. For the last two decades, she has worked at the intersection of policy, practice, research, and advocacy, with stints at Avalere Health, CMS, and GlaxoSmithKline. With her unique vantage point into the broader healthcare system, she is leading FasterCures to develop strategic approaches engaging patients in research and development, advancing and enabling a high-performing system, and building pathways to medical innovation. A strong believer that real-world evidence can save lives and improve outcomes, Dr. Carino and her work have been published in various journals, and her commentaries have appeared in Health Affairs, BioCentury, and The Hill, among others.

Steven D. Pearson, MD, MSc

Steven D. Pearson, MD, MSc is the Founder and President of the Institute for Clinical and Economic Review (ICER), an independent non-profit organization that evaluates the evidence on the value of medical tests, treatments, and delivery system innovations to encourage collaborative efforts to improve patient care and control costs. Prominent among its evidence reports are ICER reviews of new drugs that include full assessments of clinical and cost-effectiveness along with suggested “value-based price benchmarks” to inform policymakers and guide price and coverage negotiation. ICER convenes public hearings to discuss its evidence reports under the auspices of the California Technology Assessment Forum (CTAF) and Comparative Effectiveness Public Advisory Councils (CEPAC) in New England and the Midwest. At these meetings independent groups of evidence experts and public representatives engage with all stakeholders to debate the strength of evidence and provide recommendations on how best to apply the best evidence to clinical practice and coverage policies. Dr. Pearson is a Lecturer in the Department of Population Medicine at Harvard Medical School and also serves as Visiting Scientist in the Department of Bioethics at the National Institutes of Health. His published work includes over 100 articles on quality of care, the role of evidence-based medicine within the health care system, and related clinical, ethical, and organizational policy challenges. His book, No Margin, No Mission: Health Care Organizations and the Quest for Ethical Excellence, was published by Oxford University Press.

Among his past roles, from 2005-2006 Dr. Pearson served during the Bush Administration as Special Advisor on Technology and Coverage Policy within the Coverage and Analysis Group at the Centers for Medicare and Medicaid Services. Dr. Pearson has also been a Senior Visiting Fellow at England’s National Institute for Health and Care Excellence (NICE), a Board Director of HTAi, the international society of health technology assessment agencies, and the Vice Chair of the Medicare Evidence Development and Coverage Advisory Committee (MedCAC).



View All Materials on this Topic or Go Back to View More Materials